Aquestive Therapeutics, Inc. AQST Severance liability
Severance liability at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept aqst:SeveranceCostLiability.
The official record: Aquestive Therapeutics, Inc.’s 10-K, filed March 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s severance liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s severance liability?
- Aquestive Therapeutics, Inc. (AQST) reported severance liability of $356K in Q4 2024.
- What does severance liability mean?
- This represents the accrued liability for estimated severance payments and related benefits owed to employees as a result of restructuring or workforce reductions. It reflects the immediate financial impact of organizational changes intended to improve operational efficiency. Monitoring this provides insight into the company's cost-cutting measures and potential one-time charges.